Sorrento Therapeutics

$10.05
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.45 (-4.45%) Today
+$0.38 (+3.93%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell SRNE and other stocks, options, and ETFs commission-free!

About SRNE

Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. The company was founded by Henry H. Ji in 2006 and is headquartered in San Diego, CA. The listed name for SRNE is Sorrento Therapeutics, Inc. Common Stock.

CEO
Henry H. Ji
Employees
502
Headquarters
San Diego, California
Founded
2006
Market Cap
2.95B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
13.49M
High Today
$10.36
Low Today
$9.40
Open Price
$10.09
Volume
15.16M
52 Week High
$19.39
52 Week Low
$1.55

SRNE Earnings

-$0.50
-$0.33
-$0.17
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
-$0.25 per share

You May Also Like

CDL
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure